Comparison Between Magnetic Field and Laser Therapy in Management of Trigeminal Neuralgia

Trigeminal Neuralgia Clinical Trial

Official title:

Magnetic Field and Laser Therapy in Management of Diabetic Trigeminal Neuralgia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05075707
• Other study ID #: magnetic and laser therapy
• Status: Completed
• Phase: N/A
• Start date: October 15, 2021
• Est. completion date: February 23, 2022

Study information

• Verified date: March 2022
• Source: Delta University for Science and Technology
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Trigeminal neuralgia (TN) was defined by The International Association for the Study of Pain (IASP) as severe, sudden, usually unilateral, stabbing, brief, recurrent attacks of pain in one or more distributional branches of the trigeminal nerve. The purpose of the current study will to investigate the effect of Low level laser therapy versus electromagnetic therapy on diabetic trigeminal neuralgia pain intensity and amplitude of the compound muscle action potential of the masseter and temporalis muscles in diabetic TN patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 120
• Est. completion date: February 23, 2022
• Est. primary completion date: February 22, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 25 Years to 45 Years

Eligibility

Inclusion Criteria:

• All participants will between the ages of 25 and 45, will of both sexes (male and female), diabetic type two patients with chronic trigeminal neuralgia, (from three to six months).
• Patients will awake, cooperative, and free of psychiatric issues (as determined by a psychologist) as well as difficulties resulting from orthopaedic or special sensory deficits.

Exclusion Criteria:

• Patients will ruled out if they developed TN due to a tumour, herpes zoster, or any other reason other than diabetes, such as significant coagulation dysfunction, cardiopulmonary dysfunction or previous invasive treatment (ethanol, radiofrequency, Gama-knife microvascular decompression, glycerinum injection).
• They will not have a previous disability in the face.

Related Conditions & MeSH terms

• Neuralgia
• Trigeminal Neuralgia

Intervention

Other:
• Electromagnetic therapy.
Electromagnetic therapy will be applied for 20 min/ session for (3 days/ week for two months) to the group intervention.
• Low level laser therapy (LLLT)
Low level laser therapy (LLLT) will be applied for 20 min/session laser scanner for three days each week for two months to the group intervention.

Locations

Country	Name	City	State
Egypt	AAA	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Delta University for Science and Technology

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Studies using electromyography and complex muscle action potentials	All patients' compound motor action potential amplitudes in the masseter and temporalis muscles will be evaluated before interventions.	at the beginning of the study
Primary	Studies using electromyography and complex muscle action potentials	All patients' compound motor action potential amplitudes in the masseter and temporalis muscles will be evaluated after two month of interventions.	by the end of successful two month of intervention
Primary	Visual analogue scale (VAS)	All the participants were instructed to express their pain by Visual analogue scale (VAS) before the interventions.	at the beginning of the study
Primary	Visual analogue scale (VAS)	All the participants were instructed to express their pain by Visual analogue scale (VAS) after two month of interventions.	by the end of successful two month of intervention